当前位置:首页 - 行情中心 - 微芯生物(688321) - 财务分析 - 资产负债表

微芯生物

(688321)

  

流通市值:94.80亿  总市值:94.80亿
流通股本:4.11亿   总股本:4.11亿

资产负债表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
流动资产:
货币资金467,877,634.95375,437,648.61361,592,162.79496,760,221.84
应收票据及应收账款129,465,765.36195,879,741.71144,668,902.79170,063,840.72
其中:应收票据451,936.8---
应收账款129,013,828.56195,879,741.71144,668,902.79170,063,840.72
预付款项7,080,827.288,921,461.487,687,306.216,526,004.27
其他应收款合计25,367,956.1324,712,576.5822,785,280.4618,422,391.33
存货49,931,534.9147,129,293.6327,739,241.7126,376,209.46
合同资产1,577,697.44941,920.8--
其他流动资产270,507,290.49260,346,861.73256,115,406.84248,251,500.85
流动资产平衡项目0000
流动资产合计1,104,076,109.711,130,086,854.541,092,223,550.881,136,672,124.4
非流动资产:
长期股权投资263,919,443.48268,944,219.13275,418,038.55278,530,731.06
投资性房地产119,509,742.09120,368,884.6798,930,817.5271,696,242.84
固定资产688,533,005.22692,222,974.82713,755,982.52743,583,686.71
在建工程373,603,373.56360,807,184.45357,665,877.62340,799,637.56
使用权资产12,043,085.8413,045,793.462,617,296.73,460,669.89
无形资产181,184,163.02183,986,711.92188,651,330.43193,801,571.44
开发支出426,261,234.82398,561,645.92374,185,751.07349,586,666.13
长期待摊费用5,172,326.155,236,637.795,158,865.445,646,093.22
递延所得税资产1,274,224.612,082,893.553,763,052.24,492,576.27
其他非流动资产37,898,788.3627,905,628.8741,853,277.6332,882,979.5
非流动资产平衡项目0000
非流动资产合计2,109,399,387.152,073,162,574.582,062,000,289.682,024,480,854.62
资产平衡项目0000
资产总计3,213,475,496.863,203,249,429.123,154,223,840.563,161,152,979.02
流动负债:
短期借款111,092,757.07130,112,786.24119,131,291.67114,687,272.86
应付票据及应付账款22,511,882.099,025,080.044,701,414.061,106,407.2
其中:应付票据19,000,00050,00050,000-
应付账款3,511,882.098,975,080.044,651,414.061,106,407.2
预收款项1,977,483.271,090,768.61,470,785.081,077,417.84
合同负债742,648.5279,952.88233,706.3506,439.08
应付职工薪酬25,349,952.4146,834,507.5639,712,196.0629,008,070.16
应交税费13,671,077.6714,459,908.8213,193,462.1415,180,028.93
其他应付款合计140,582,732.62148,591,565.86159,792,438.12174,068,876.56
一年内到期的非流动负债36,500,828.540,610,886.2913,194,100.0633,866,591.49
流动负债平衡项目0000
流动负债合计352,429,362.15390,805,456.29351,429,393.49369,501,104.12
非流动负债:
长期借款551,185,753.3490,728,419.96476,348,899.98427,226,326.64
应付债券416,741,101.46408,440,498.89400,685,875.06391,654,838.88
租赁负债9,393,620.9110,063,280.13849,012.68967,859.16
预计负债5,124.068,581.4412,440.2220,642.4
递延收益78,601,730.3777,039,652.1377,480,433.8977,915,495.65
递延所得税负债23,795,225.9823,447,945.1522,347,878.1121,992,150.54
其他非流动负债91,873,487.0792,819,723.1893,137,515.6691,894,336.44
非流动负债平衡项目0000
非流动负债合计1,171,596,043.151,102,548,100.881,070,862,055.61,011,671,649.71
负债平衡项目0000
负债合计1,524,025,405.31,493,353,557.171,422,291,449.091,381,172,753.83
所有者权益(或股东权益):
实收资本(或股本)411,286,794411,286,794411,286,794411,286,794
其他权益工具123,770,746.68123,770,746.68123,770,746.68123,770,746.68
资本公积1,137,751,002.481,137,751,002.481,139,670,479.951,139,670,479.95
减:库存股115,319,969.64113,066,135.2113,066,135.2113,066,135.2
其他综合收益7,433,632.497,320,932.918,193,160.738,634,605.58
盈余公积25,250,701.4625,250,701.4625,250,701.4625,250,701.46
未分配利润99,277,184.09117,581,829.62136,826,643.85184,433,032.72
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计1,689,450,091.561,709,895,871.951,731,932,391.471,779,980,225.19
股东权益平衡项目0000
股东权益合计1,689,450,091.561,709,895,871.951,731,932,391.471,779,980,225.19
负债和股东权益合计3,213,475,496.863,203,249,429.123,154,223,840.563,161,152,979.02
公告日期2024-04-292024-03-302023-10-312023-08-12
审计意见(境内)标准无保留意见
TOP↑